Literature DB >> 11816794

Dysregulation of cellular calcium homeostasis in Alzheimer's disease: bad genes and bad habits.

M P Mattson1, S L Chan.   

Abstract

Calcium is one of the most important intracellular messengers in the brain, being essential for neuronal development, synaptic transmission and plasticity, and the regulation of various metabolic pathways. The findings reviewed in the present article suggest that calcium also plays a prominent role in the pathogenesis of Alzheimer's disease (AD). Associations between the pathological hallmarks ofAD (neurofibrillary tangles [NFT] and amyloid plaques) and perturbed cellular calcium homeostasis have been established in studies of patients, and in animal and cell culture models of AD. Studies of the effects of mutations in the beta-amyloid precursor protein (APP) and presenilins on neuronal plasticity and survival have provided insight into the molecular cascades that result in synaptic dysfunction and neuronal degeneration in AD. Central to the neurodegenerative process is the inability of neurons to properly regulate intracellular calcium levels. Increased levels of amyloid beta-peptide (Abeta) induce oxidative stress, which impairs cellular ion homeostasis and energy metabolism and renders neurons vulnerable to apoptosis and excitotoxicity. Subtoxic levels of Abeta may induce synaptic dysfunction by impairing multiple signal transduction pathways. Presenilin mutations perturb calcium homeostasis in the endoplasmic reticulum in a way that sensitizes neurons to apoptosis and excitotoxicity; links between aberrant calcium regulation and altered APP processing are emerging. Environmental risk factors for AD are being identified and may include high calorie diets, folic acid insufficiency, and a low level of intellectual activity (bad habits); in each case, the environmental factor impacts on neuronal calcium homeostasis. Low calorie diets and intellectual activity may guard against AD by stimulating production of neurotrophic factors and chaperone proteins. The emerging picture of the cell and molecular biology of AD is revealing novel preventative and therapeutic strategies for eradicating this growing epidemic of the elderly.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11816794     DOI: 10.1385/JMN:17:2:205

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  183 in total

1.  Glucose deprivation elicits neurofibrillary tangle-like antigenic changes in hippocampal neurons: prevention by NGF and bFGF.

Authors:  B Cheng; M P Mattson
Journal:  Exp Neurol       Date:  1992-08       Impact factor: 5.330

Review 2.  NF-kappaB in neuronal plasticity and neurodegenerative disorders.

Authors:  M P Mattson; S Camandola
Journal:  J Clin Invest       Date:  2001-02       Impact factor: 14.808

3.  Nicastrin modulates presenilin-mediated notch/glp-1 signal transduction and betaAPP processing.

Authors:  G Yu; M Nishimura; S Arawaka; D Levitan; L Zhang; A Tandon; Y Q Song; E Rogaeva; F Chen; T Kawarai; A Supala; L Levesque; H Yu; D S Yang; E Holmes; P Milman; Y Liang; D M Zhang; D H Xu; C Sato; E Rogaev; M Smith; C Janus; Y Zhang; R Aebersold; L S Farrer; S Sorbi; A Bruni; P Fraser; P St George-Hyslop
Journal:  Nature       Date:  2000-09-07       Impact factor: 49.962

4.  Elevated intracellular calcium concentration increases secretory processing of the amyloid precursor protein by a tyrosine phosphorylation-dependent mechanism.

Authors:  M A Petryniak; R J Wurtman; B E Slack
Journal:  Biochem J       Date:  1996-12-15       Impact factor: 3.857

Review 5.  Anti-inflammatory drugs in the fight against Alzheimer's disease.

Authors:  P L McGeer; E G McGeer
Journal:  Ann N Y Acad Sci       Date:  1996-01-17       Impact factor: 5.691

6.  Identification of syntaxin 1A as a novel binding protein for presenilin-1.

Authors:  S K Smith; H A Anderson; G Yu; A G Robertson; S J Allen; S J Tyler; R L Naylor; G Mason; G W Wilcock; P A Roche; P E Fraser; D Dawbarn
Journal:  Brain Res Mol Brain Res       Date:  2000-05-31

7.  FAD mutations in presenilin-1 or amyloid precursor protein decrease the efficacy of a gamma-secretase inhibitor: evidence for direct involvement of PS1 in the gamma-secretase cleavage complex.

Authors:  W Xia; B L Ostaszewski; W T Kimberly; T Rahmati; C L Moore; M S Wolfe; D J Selkoe
Journal:  Neurobiol Dis       Date:  2000-12       Impact factor: 5.996

8.  Calbindin D28k blocks the proapoptotic actions of mutant presenilin 1: reduced oxidative stress and preserved mitochondrial function.

Authors:  Q Guo; S Christakos; N Robinson; M P Mattson
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-17       Impact factor: 11.205

9.  In vivo 2-deoxyglucose administration preserves glucose and glutamate transport and mitochondrial function in cortical synaptic terminals after exposure to amyloid beta-peptide and iron: evidence for a stress response.

Authors:  Z H Guo; M P Mattson
Journal:  Exp Neurol       Date:  2000-11       Impact factor: 5.330

10.  Proteolytic processing of Alzheimer's disease beta A4 amyloid precursor protein in human platelets.

Authors:  Q X Li; G Evin; D H Small; G Multhaup; K Beyreuther; C L Masters
Journal:  J Biol Chem       Date:  1995-06-09       Impact factor: 5.157

View more
  48 in total

1.  Novel mechanism of increased Ca2+ release following oxidative stress in neuronal cells involves type 2 inositol-1,4,5-trisphosphate receptors.

Authors:  S Kaja; R S Duncan; S Longoria; J D Hilgenberg; A J Payne; N M Desai; R A Parikh; S L Burroughs; E V Gregg; D L Goad; P Koulen
Journal:  Neuroscience       Date:  2010-11-11       Impact factor: 3.590

2.  Involvement of α7 nAChR signaling cascade in epigallocatechin gallate suppression of β-amyloid-induced apoptotic cortical neuronal insults.

Authors:  Xijing Zhang; Mingmei Wu; Fan Lu; Na Luo; Zu-Ping He; Hao Yang
Journal:  Mol Neurobiol       Date:  2013-06-27       Impact factor: 5.590

Review 3.  Hippocampal neuroplasticity induced by early-life stress: functional and molecular aspects.

Authors:  Kristina A Fenoglio; Kristen L Brunson; Tallie Z Baram
Journal:  Front Neuroendocrinol       Date:  2006-04-17       Impact factor: 8.606

4.  Protection against beta-amyloid induced abnormal synaptic function and cell death by Ginkgolide J.

Authors:  Ottavio Vitolo; Bing Gong; Zixuan Cao; Hideki Ishii; Stanislav Jaracz; Koji Nakanishi; Ottavio Arancio; Sergei V Dzyuba; Roger Lefort; Michael Shelanski
Journal:  Neurobiol Aging       Date:  2007-07-20       Impact factor: 4.673

5.  The homocysteine-inducible endoplasmic reticulum stress protein counteracts calcium store depletion and induction of CCAAT enhancer-binding protein homologous protein in a neurotoxin model of Parkinson disease.

Authors:  Srinivasulu Chigurupati; Zelan Wei; Cherine Belal; Myriam Vandermey; George A Kyriazis; Thiruma V Arumugam; Sic L Chan
Journal:  J Biol Chem       Date:  2009-05-15       Impact factor: 5.157

6.  Differential expression and redox proteomics analyses of an Alzheimer disease transgenic mouse model: effects of the amyloid-β peptide of amyloid precursor protein.

Authors:  R A S Robinson; M B Lange; R Sultana; V Galvan; J Fombonne; O Gorostiza; J Zhang; G Warrier; J Cai; W M Pierce; D E Bredesen; D A Butterfield
Journal:  Neuroscience       Date:  2011-01-09       Impact factor: 3.590

Review 7.  Brain metabolism and Alzheimer's disease: the prospect of a metabolite-based therapy.

Authors:  S C Thomas; A Alhasawi; V P Appanna; C Auger; V D Appanna
Journal:  J Nutr Health Aging       Date:  2015-01       Impact factor: 4.075

Review 8.  Mechanisms of HIV-1 Tat neurotoxicity via CDK5 translocation and hyper-activation: role in HIV-associated neurocognitive disorders.

Authors:  Jerel Adam Fields; Wilmar Dumaop; Leslie Crews; Anthony Adame; Brian Spencer; Jeff Metcalf; Johnny He; Edward Rockenstein; Eliezer Masliah
Journal:  Curr HIV Res       Date:  2015       Impact factor: 1.581

9.  Decreased levels of PSD95 and two associated proteins and increased levels of BCl2 and caspase 3 in hippocampus from subjects with amnestic mild cognitive impairment: Insights into their potential roles for loss of synapses and memory, accumulation of Abeta, and neurodegeneration in a prodromal stage of Alzheimer's disease.

Authors:  Rukhsana Sultana; William A Banks; D Allan Butterfield
Journal:  J Neurosci Res       Date:  2010-02-15       Impact factor: 4.164

10.  Acute dosing of latrepirdine (Dimebon), a possible Alzheimer therapeutic, elevates extracellular amyloid-beta levels in vitro and in vivo.

Authors:  John W Steele; Soong H Kim; John R Cirrito; Deborah K Verges; Jessica L Restivo; David Westaway; Paul Fraser; Peter St George Hyslop; Mary Sano; Ilya Bezprozvanny; Michelle E Ehrlich; David M Holtzman; Sam Gandy
Journal:  Mol Neurodegener       Date:  2009-12-17       Impact factor: 14.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.